STOCK TITAN

Bausch + Lomb Will Release Second-Quarter 2023 Financial Results on August 2

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its second-quarter 2023 financial results on Wednesday, Aug. 2, 2023. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the call.

Conference Call Details

Date:

Wednesday, Aug. 2, 2023

 

Time:

8 a.m. ET

 

Webcast:

https://www.webcaster4.com/Webcast/Page/2883/47446

 

Participant Event Dial-in:

+1 (888) 506-0062 (North America)

+1 (973) 528-0011 (International)

 

Participant Access Code:

360419

 

Replay Dial-in:

+1 (877) 481-4010 (North America)

+1 (919) 882-2331 (International)

 

Replay Passcode:

47446 (replay available until Aug. 16, 2023)

About Bausch + Lomb

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on Twitter, LinkedIn, Facebook and Instagram.

© 2023 Bausch + Lomb.

Investors:

George Gadkowski

george.gadkowski@bausch.com



Allison Ryan

allison.ryan@bausch.com

(877) 354-3705 (toll free)

(908) 927-0735



Media:

T.J. Crawford

tj.crawford@bausch.com

(908) 705-2851



Lainie Keller

lainie.keller@bausch.com

(908) 927-1198

Source: Bausch + Lomb Corporation

Bausch + Lomb Corporation

NYSE:BLCO

BLCO Rankings

BLCO Latest News

BLCO Stock Data

6.34B
40.51M
88.47%
10.91%
0.27%
Medical Instruments & Supplies
Ophthalmic Goods
Link
United States of America
VAUGHAN